390 related articles for article (PubMed ID: 28792479)
1. Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects.
Kruspe S; Giangrande PH
Biomedicines; 2017 Aug; 5(3):. PubMed ID: 28792479
[TBL] [Abstract][Full Text] [Related]
2. Current progress on aptamer-targeted oligonucleotide therapeutics.
Dassie JP; Giangrande PH
Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
[TBL] [Abstract][Full Text] [Related]
3. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
Sivakumar P; Kim S; Kang HC; Shim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
[TBL] [Abstract][Full Text] [Related]
4. Current progress of RNA aptamer-based therapeutics.
Zhou J; Bobbin ML; Burnett JC; Rossi JJ
Front Genet; 2012; 3():234. PubMed ID: 23130020
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-siRNA chimeras for HIV.
Takahashi M; Burnett JC; Rossi JJ
Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
[TBL] [Abstract][Full Text] [Related]
6. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
7. Advances in aptamer-mediated targeted delivery system for cancer treatment.
He S; Du Y; Tao H; Duan H
Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-targeted cell-specific RNA interference.
Zhou J; Rossi JJ
Silence; 2010 Feb; 1(1):4. PubMed ID: 20226078
[TBL] [Abstract][Full Text] [Related]
9. Aptamer-siRNA chimeras: Promising tools for targeting HER2 signaling in cancer.
Dhanya CR; Mary AS; Madhavan M
Chem Biol Drug Des; 2023 May; 101(5):1162-1180. PubMed ID: 36099164
[TBL] [Abstract][Full Text] [Related]
10. Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers.
Hernandez LI; Flenker KS; Hernandez FJ; Klingelhutz AJ; McNamara JO; Giangrande PH
Pharmaceuticals (Basel); 2013 Mar; 6(3):295-319. PubMed ID: 23894227
[TBL] [Abstract][Full Text] [Related]
11. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
Kruspe S; Giangrande PH
Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
[TBL] [Abstract][Full Text] [Related]
12. Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs.
Khanali J; Azangou-Khyavy M; Asaadi Y; Jamalkhah M; Kiani J
Front Microbiol; 2021; 12():758948. PubMed ID: 34858370
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells.
Esposito CL; Catuogno S; de Franciscis V
J RNAi Gene Silencing; 2014; 10():500-6. PubMed ID: 25414727
[TBL] [Abstract][Full Text] [Related]
14. Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy.
Aaldering LJ; Tayeb H; Krishnan S; Fletcher S; Wilton SD; Veedu RN
RNA Biol; 2015; 12(4):412-25. PubMed ID: 25849197
[TBL] [Abstract][Full Text] [Related]
15. Albumin-Binding Aptamer Chimeras for Improved siRNA Bioavailability.
Rosch JC; Hoogenboezem EN; Sorets AG; Duvall CL; Lippmann ES
Cell Mol Bioeng; 2022 Apr; 15(2):161-173. PubMed ID: 35401842
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of cell-internalizing aptamers.
Zhou J; Rossi JJ
Curr Top Med Chem; 2009; 9(12):1144-57. PubMed ID: 19860714
[TBL] [Abstract][Full Text] [Related]
17. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
Catuogno S; Esposito CL; Giangrande PH
Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
[TBL] [Abstract][Full Text] [Related]
18. Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery.
Gilboa E; Berezhnoy A; Schrand B
Cancer Immunol Res; 2015 Nov; 3(11):1195-200. PubMed ID: 26541880
[TBL] [Abstract][Full Text] [Related]
19. RNA-based therapeutics: current progress and future prospects.
Burnett JC; Rossi JJ
Chem Biol; 2012 Jan; 19(1):60-71. PubMed ID: 22284355
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide aptamers: new tools for targeted cancer therapy.
Sun H; Zhu X; Lu PY; Rosato RR; Tan W; Zu Y
Mol Ther Nucleic Acids; 2014 Aug; 3(8):e182. PubMed ID: 25093706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
